ArticleQJM : monthly journal of the Association of Physicians2022

Successful graded-dose challenge of the Janssen vaccine against SARS-CoV-2 in a high-risk patient.

N Jhawar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.